◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Alcon AG (ALC)

Name: Alcon AG（ALC）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

HEALTHCARE · ウォール街（米国） · 最終更新: 2026-07-23

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

主要指標

時価総額: $36 billion
売上高（2025-12-31 期末の会計年度）: $10.4B
当期純利益: $980M
売上総利益率: 55.2%
純利益率: 9.4%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31
売上高合計	$10.6B	$10.4B	$9.9B	$9.5B	$8.7B	$8.3B	$6.8B	$7.5B	$7.2B	$6.8B	$6.6B	$6.5B
売上総利益	$5.8B	$5.7B	$5.5B	$5.2B	$4.7B	$4.7B	$2.9B	$3.7B	$3.2B	$3.2B	$3.1B	$3.1B
売上総利益率 %	54.9%	55.2%	55.6%	55.5%	54.5%	56.1%	43.0%	48.8%	44.6%	47.2%	47.2%	47.9%
営業利益（EBIT）	$1.3B	$1.4B	$1.4B	$1.0B	$672M	$580M	($482M)	($187M)	($248M)	($77M)	$10M	$401M
営業利益率 %	12.3%	13.1%	14.3%	11.0%	7.7%	7.0%	-7.0%	-2.5%	-3.5%	-1.1%	0.1%	6.2%
当期純利益	$815M	$980M	$1.0B	$974M	$335M	$376M	($531M)	($656M)	($227M)	$256M	($170M)	$296M
純利益率 %	7.7%	9.4%	10.3%	10.3%	3.8%	4.5%	-7.8%	-8.7%	-3.2%	3.8%	-2.6%	4.5%
EBITDA	$2.4B	$2.4B	$2.7B	$2.2B	$1.8B	$1.8B	$1.2B	$1.3B	$1.4B	$1.2B	$1.2B	$1.6B
1株当たり利益（EPS）	$1.65	$1.98	$2.05	$1.96	$0.68	$0.76	$-1.09	$-1.34	$-0.46	$0.52	$-0.35	$0.61
発行済株式数（百万株）	490M	496M	498M	496M	494M	493M	489M	488M	489M	489M	489M	489M

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は ALC のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/ALC

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.